{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:44:57Z","timestamp":1791895497231,"version":"4.3.4"},"reference-count":42,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Tumor necrosis factor receptor-associated factor 3 (TRAF3)-interacting protein 3 (TRAF3IP3) expressed in various tumor cell. However, its role in hepatocellular carcinoma (HCC) was unclear. We aimed to demonstrate the relationship between TRAF3IP3 and HCC and explore the potential role of TRAF3IP3 in HCC.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), Genotype-Tissue Expression (GTEx), KM-Plotter, University of Alabama at Birmingham Cancer data analysis Portal (UALCAN), and Xiantao Academic Online Website were utilized for the systematic analysis of TRAF3IP3. This analysis included mRNA expression, protein expression, prognostic value, enrichment analysis, and immune cell infiltration in HCC. Subsequently, immunohistochemistry was performed to assess the expression levels of TRAF3IP3 in both cancer and non-cancer tissues of patients with HCC.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Analysis of public databases and immunohistochemical staining on 20 pairs of samples confirmed a decrease in TRAF3IP3 expression in HCC. Both the TCGA database and <jats:uri xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE14520\">GSE14520<\/jats:uri> indicated that patients with high TRAF3IP3 expression had a more favorable prognosis in terms of overall survival (OS) and progression-free interval (PFI), as shown by KM curve results. Multivariate Cox regression analysis further demonstrated that high TRAF3IP3 expression was an independent protective factor for HCC prognosis (hazard ratio (HR): 0.619, 95% confidence interval (CI) [0.399\u20130.959]; <jats:italic>p<\/jats:italic> &lt; 0.05). In the high TRAF3IP3 expression group, various immune response-related molecular pathways, particularly B lymphocyte-mediated pathways, were activated. The level of TRAF3IP3 expression showed a significant correlation with the presence of tumor-infiltrating CD8+ T cells. Additionally, a positive correlation was observed between immunophenoscore (IPS) and TRAF3IP3 expression. Notably, the half-maximal inhibitory concentration (IC50) of commonly used chemotherapeutic drugs, such as lapatinib and mitomycin, was inversely associated with TRAF3IP3 expression in HCC patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>TRAF3IP3 may be as a novel and promising biomarker for prognosis prediction and immunological evaluation of HCC.<\/jats:p>\n<\/jats:sec>","DOI":"10.7717\/peerj.18538","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T08:23:19Z","timestamp":1733991799000},"page":"e18538","source":"Crossref","is-referenced-by-count":1,"title":["Study of TRAF3IP3 for prognosis and immune infiltration in hepatocellular carcinoma"],"prefix":"10.7717","volume":"12","author":[{"given":"Xing","family":"Wang","sequence":"first","affiliation":[{"name":"Hebei Key Laboratory of Gastroenterology, Hebei Institute of Gastroenterology, Hebei Clinical Research Center for Digestive Diseases, Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Gao","sequence":"additional","affiliation":[{"name":"Hebei Key Laboratory of Gastroenterology, Hebei Institute of Gastroenterology, Hebei Clinical Research Center for Digestive Diseases, Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Airu","family":"Liu","sequence":"additional","affiliation":[{"name":"Hebei Key Laboratory of Gastroenterology, Hebei Institute of Gastroenterology, Hebei Clinical Research Center for Digestive Diseases, Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qin","sequence":"additional","affiliation":[{"name":"Central Laboratory, Affiliated Hospital of Hebei University, Hebei Collaborative Innovation Center of Tumor Microecological Metabolism Regulation, Hebei Key Laboratory of Precise Imaging of Inflammation Related Tumors, Hebei University, Baoding, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yu","family":"Ni","sequence":"additional","affiliation":[{"name":"The Affiliated Hospital of Hebei University, School of Basic Medical Science, Hebei University, Baoding, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Lan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hebei Key Laboratory of Gastroenterology, Hebei Institute of Gastroenterology, Hebei Clinical Research Center for Digestive Diseases, Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4443","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"issue":"6","key":"10.7717\/peerj.18538\/ref-1","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","article-title":"Conserved pan-cancer microenvironment subtypes predict response to immunotherapy","volume":"39","author":"Bagaev","year":"2021","journal-title":"Cancer Cell"},{"issue":"5","key":"10.7717\/peerj.18538\/ref-2","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.2353\/ajpath.2008.070988","article-title":"Molecular characterization of human breast tumor vascular cells","volume":"172","author":"Bhati","year":"2008","journal-title":"The American Journal of Pathology"},{"issue":"11","key":"10.7717\/peerj.18538\/ref-3","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nature Reviews Cancer"},{"issue":"1","key":"10.7717\/peerj.18538\/ref-4","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Reports"},{"issue":"3","key":"10.7717\/peerj.18538\/ref-5","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/liv.15102","article-title":"Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinoma","volume":"42","author":"Cheon","year":"2022","journal-title":"Liver International"},{"issue":"3","key":"10.7717\/peerj.18538\/ref-6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/s0014-5793(03)01072-x","article-title":"T3JAM, a novel protein that specifically interacts with TRAF3 and promotes the activation of JNK1","volume":"553","author":"Dadgostar","year":"2003","journal-title":"FEBS Letters"},{"key":"10.7717\/peerj.18538\/ref-7","doi-asserted-by":"publisher","first-page":"2797033","DOI":"10.1155\/2022\/2797033","article-title":"Identification of key genes in the HBV-related HCC immune microenvironment using integrated bioinformatics analysis","volume":"2022","author":"Ding","year":"2022","journal-title":"Journal of Oncology"},{"issue":"6","key":"10.7717\/peerj.18538\/ref-8","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review","volume":"234","author":"Farhood","year":"2018","journal-title":"Journal of Cellular Physiology"},{"issue":"1","key":"10.7717\/peerj.18538\/ref-9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40880-019-0368-6","article-title":"Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?","volume":"39","author":"Feng","year":"2019","journal-title":"Cancer Communications"},{"issue":"9","key":"10.7717\/peerj.18538\/ref-10","doi-asserted-by":"publisher","first-page":"e107468","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels","volume":"9","author":"Geeleher","year":"2014","journal-title":"PLOS ONE"},{"issue":"S1","key":"10.7717\/peerj.18538\/ref-11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/hep.31325","article-title":"Surgical treatments of hepatobiliary cancers","volume":"73","author":"Gunasekaran","year":"2021","journal-title":"Hepatology"},{"key":"10.7717\/peerj.18538\/ref-12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3389\/fimmu.2022.861525","article-title":"The heterogeneity of immune cell infiltration landscape and its immunotherapeutic implications in hepatocellular carcinoma","volume":"13","author":"Guo","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.7717\/peerj.18538\/ref-13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3389\/fcell.2021.775462","article-title":"Targeting immune cells in the tumor microenvironment of HCC: new opportunities and challenges","volume":"9","author":"Hao","year":"2021","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"3","key":"10.7717\/peerj.18538\/ref-14","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1053\/j.gastro.2013.01.002","article-title":"Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma","volume":"144","author":"Hernandez-Gea","year":"2013","journal-title":"Gastroenterology"},{"issue":"18","key":"10.7717\/peerj.18538\/ref-15","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.Can-18-3962","article-title":"The Tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Research"},{"issue":"1","key":"10.7717\/peerj.18538\/ref-16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ccell.2020.09.004","article-title":"Immunometabolic interplay in the tumor microenvironment","volume":"39","author":"Kaymak","year":"2020","journal-title":"Cancer Cell"},{"issue":"6","key":"10.7717\/peerj.18538\/ref-17","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1158\/1078-0432.Ccr-22-1031","article-title":"Cancer-associated fibroblasts in inflammation and antitumor immunity","volume":"29","author":"Kennel","year":"2022","journal-title":"Clinical Cancer Research"},{"key":"10.7717\/peerj.18538\/ref-18","doi-asserted-by":"publisher","first-page":"776834","DOI":"10.3389\/fonc.2022.776834","article-title":"TRAF3IP3 promotes glioma progression through the ERK signaling pathway","volume":"12","author":"Lin","year":"2022","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"10.7717\/peerj.18538\/ref-19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/TP.0000000000002466","article-title":"Steatosis in liver transplantation: current limitations and future strategies","volume":"103","author":"Linares","year":"2019","journal-title":"Transplantation"},{"key":"10.7717\/peerj.18538\/ref-20","doi-asserted-by":"publisher","first-page":"e11911","DOI":"10.7717\/peerj.11911","article-title":"A four-gene prognostic signature for predicting the overall survival of patients with lung adenocarcinoma","volume":"9","author":"Liu","year":"2021","journal-title":"PeerJ"},{"key":"10.7717\/peerj.18538\/ref-21","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.3389\/fgene.2022.833928","article-title":"A necroptosis-related lncrna-based signature to predict prognosis and probe molecular characteristics of stomach adenocarcinoma","volume":"13","author":"Luo","year":"2022b","journal-title":"Frontiers in Genetics"},{"key":"10.7717\/peerj.18538\/ref-22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12916-021-02201-3","article-title":"Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma","volume":"20","author":"Luo","year":"2022a","journal-title":"BMC Medicine"},{"issue":"3","key":"10.7717\/peerj.18538\/ref-23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/CMR.0000000000000440","article-title":"TRAF3-interacting protein 3, a new oncotarget, promotes tumor growth in melanoma","volume":"28","author":"Nasarre","year":"2018","journal-title":"Melanoma Research"},{"issue":"5","key":"10.7717\/peerj.18538\/ref-24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nature Methods"},{"issue":"8","key":"10.7717\/peerj.18538\/ref-25","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/onc.2009.416","article-title":"Immune infiltration in human tumors: a prognostic factor that should not be ignored","volume":"29","author":"Pag\u00e8s","year":"2010","journal-title":"Oncogene"},{"issue":"8","key":"10.7717\/peerj.18538\/ref-26","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3748\/wjg.v26.i8.789","article-title":"Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma","volume":"26","author":"Pan","year":"2020","journal-title":"World Journal of Gastroenterology"},{"issue":"1","key":"10.7717\/peerj.18538\/ref-27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/cei.12658","article-title":"TRAF3IP3, a novel autophagy up-regulated gene, is involved in marginal zone B lymphocyte development and survival","volume":"182","author":"Peng","year":"2015","journal-title":"Clinical and Experimental Immunology"},{"issue":"2","key":"10.7717\/peerj.18538\/ref-28","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3390\/cancers13020192","article-title":"Stereotactic radiotherapy for hepatocellular carcinoma, radiosensitization strategies and radiation-immunotherapy combination","volume":"13","author":"Perez-Romasanta","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.7717\/peerj.18538\/ref-29","doi-asserted-by":"publisher","first-page":"7235","DOI":"10.2147\/IJGM.S333904","article-title":"Identification of ABCC5 among ATP-binding cassette transporter family as a new biomarker for hepatocellular carcinoma based on bioinformatics analysis","volume":"14","author":"Qiu","year":"2021","journal-title":"International Journal of General Medicine"},{"key":"10.7717\/peerj.18538\/ref-30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12935-024-03309-1","article-title":"High LGALS3 expression induced by HCP5\/hsa-miR-27b-3p correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma","volume":"24","author":"Ren","year":"2024","journal-title":"Cancer Cell International"},{"key":"10.7717\/peerj.18538\/ref-31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3389\/fgene.2018.00183","article-title":"Network-based predictors of progression in head and neck squamous cell carcinoma","volume":"9","author":"Sanati","year":"2018","journal-title":"Frontiers in Genetics"},{"issue":"43","key":"10.7717\/peerj.18538\/ref-32","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.7717\/peerj.18538\/ref-33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"1","key":"10.7717\/peerj.18538\/ref-34","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s13578-019-0342-7","article-title":"Macrophages and hepatocellular carcinoma","volume":"9","author":"Tian","year":"2019","journal-title":"Cell & Bioscience"},{"issue":"5","key":"10.7717\/peerj.18538\/ref-35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc.2016.36","article-title":"Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy","volume":"16","author":"Topalian","year":"2016","journal-title":"Nature Reviews Cancer"},{"issue":"7","key":"10.7717\/peerj.18538\/ref-36","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.18632\/aging.204012","article-title":"An immune subtype-related prognostic signature of hepatocellular carcinoma based on single-cell sequencing analysis","volume":"14","author":"Xie","year":"2022","journal-title":"Aging"},{"issue":"Suppl. 5","key":"10.7717\/peerj.18538\/ref-37","doi-asserted-by":"publisher","first-page":"e436","DOI":"10.1016\/j.wneu.2021.01.006","article-title":"High TRAF3IP3 level predicts poor prognosis of patients with gliomas","volume":"148","author":"Yang","year":"2021","journal-title":"World Neurosurgery"},{"key":"10.7717\/peerj.18538\/ref-38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12957-018-1312-y","article-title":"M2-polarized tumor-associated macrophages facilitated migration and epithelial-mesenchymal transition of HCC cells via the TLR4\/STAT3 signaling pathway","volume":"16","author":"Yao","year":"2018","journal-title":"World Journal of Surgical Oncology"},{"key":"10.7717\/peerj.18538\/ref-39","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nature Communications"},{"issue":"9","key":"10.7717\/peerj.18538\/ref-40","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1084\/jem.20180397","article-title":"Metabolic control of regulatory T cell stability and function by TRAF3IP3 at the lysosome","volume":"215","author":"Yu","year":"2018","journal-title":"Journal of Experimental Medicine"},{"issue":"5","key":"10.7717\/peerj.18538\/ref-41","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS: A Journal of Integrative Biology"},{"issue":"5","key":"10.7717\/peerj.18538\/ref-42","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/S2214-109X(18)30127-X","article-title":"Changing cancer survival in China during 2003\u201315: a pooled analysis of 17 population-based cancer registries","volume":"6","author":"Zeng","year":"2018","journal-title":"The Lancet Global Health"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/18538.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/18538.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/18538.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/18538.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T08:23:31Z","timestamp":1733991811000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/18538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":42,"alternative-id":["10.7717\/peerj.18538"],"URL":"https:\/\/doi.org\/10.7717\/peerj.18538","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,12]]},"article-number":"e18538"}}